GlobeNewswire
Coverage by GlobeNewswire as tracked by Newsylist.
Blood glucose levels are lower when you eat with a loved one
Updated: Electra says $350M IPO will help it become a commercial biotech
Wendy’s operator Meritage files for bankruptcy
Burger franchisee closes 60 stores, files Chapter 11 bankruptcy
Why AI Isn’t Likely to Wipe Out Humanity With Bioweapons
A biotech hedge fund births a new immunology company
Ozempic-maker turns to Anthropic to turbocharge medical research
Money Is Flowing Into Space Start-Ups. Some Investors See a SpaceX Effect.
No more Nordisk as Novo goes it alone amid rebranding push
U.S. Gets Minority Stakes in Some Quantum Computing Companies in $300 Million CHIPS Act Funding Deal
Bikini baristas preliminarily awarded $1.8M in pay violations, attorneys say
Novo Nordisk Says Wegovy Shot Helped Children Lose Weight in Trial
City in Lehigh Valley ranked as most challenging place to live with asthma in continental US
Exclusive | Ernst & Young Is Giving $100 Million in Bonuses to Staff for ‘Human’ Skills
Column | I’m an oncologist. Every man should know this about prostate cancer.
Hims & Hers CEO says FTC lawsuit misunderstands how the company works
Google Pixel 11 cases finally let the phone colors shine through
Birdsong similar to human language, study finds
A compendium of next-generation patient-derived models for diverse cancers
Rocket Lab, STR win Space Force contracts for airborne-target tracking
Novo drug trial fail deals setback to bid to expand beyond obesity
A Deluge of A.I. Computing Power Is About to Come Online, Fueling Major Leaps
6 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Grant Thornton Advisors to buy CBIZ in $5 billion deal, expand US accounting reach
4 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
FDA staff flags data concerns about Capricor's therapy; shares plunge
Capricor Therapeutics shares are plummeting after FDA staff disputed the company's claims of Phase 3 success for its DMD cell therapy.
Argenx to Buy Forte Biosciences for $2.2 Billion
8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Exclusive | Nvidia Bets on Ilya Sutskever’s New AI Lab to Expand Compute Reach
Nvidia is making a substantial investment in Ilya Sutskever’s new AI lab, Safe Superintelligence (SSI), to expand its compute reach.
AC Black Flag Resynced Update 1.04 Live Tomorrow, Patch Notes Revealed
Beloved pizza chain to close up to 50 locations
A popular pizza chain is shutting down up to 50 locations following significant financial losses.
Panda Express Is Bringing Back the ‘Best Thing on the Menu,’ According to Fans
8 news sources are covering this Business story right now — Newsylist is tracking how fast it spreads.
Eli Lilly's Market Cap Balloons, Again, On This IPO's Setback
Eli Lilly's market capitalization has risen following a setback for Kailera's oral GLP-1 obesity drug trials in China.
FDA approves Vera Therapeutics kidney disease treatment
The FDA has approved Vera Therapeutics' drug Trutakna to treat primary IgA nephropathy, sparking a new market competition for kidney disease treatments.
Assassin’s Creed: Black Flag Resynced Launch Times And Preload Schedule Revealed
Assassin's Creed Black Flag Resynced achieves record-breaking Steam sales while simultaneously triggering layoffs at Ubisoft Barcelona.
FDA’s top gene therapy regulator is leaving his role
Ipsen to Buy Kartos Therapeutics for Up to $1.75 Billion
French biotech Ipsen is acquiring Kartos Therapeutics in a deal valued at up to $1.75 billion to expand its hemato-oncology pipeline.
NASA Selects Rocket Lab to Launch Sun, Earth Science Missions
ON Semiconductor strikes $7 billion deal for Synaptics in physical AI push
ON Semiconductor strikes $7 billion deal for Synaptics